ATR and neoplasm: The presence of mutations in the ATR gene in combination with oncogenic stress caused by high expression of KRAS can cause synthetic lethality of tumor cells or contribute to the loss of functioning of tumor suppressor genes, particularly TP53, and increased genomic instability [21, 22].